Homeopathic mistletoe adverse reaction mimics nodal involvement in 18F-FDG PET/CT performed for evaluation of response to chemotherapy in lymphoma
Rev Esp Med Nucl Imagen Mol. 2017 Mar-Apr;36(2):110-112.
doi: 10.1016/j.remn.2016.07.005.
Epub 2016 Sep 13.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Medicina Nuclear, Hospital Universitario Dr. Peset, Valencia, Spain. Electronic address: abreu_ped@hotmail.com.
- 2 Servicio de Medicina Nuclear y PET/TC, Hospital 9 de Octubre, Valencia, Spain.
- 3 Servicio de Medicina Nuclear, Hospital Universitario Dr. Peset, Valencia, Spain.
Abstract
Some patients use complementary medicine. We present a patient with Hodgkin's lymphoma, scanned with 18F-FDG PET/CT for evaluation of response after chemotherapy, who was self-administering mistletoe as a homeopathic medicine product. The careful review of the images of the entire scan and patient collaboration in anamnesis were crucial to avoid a false positive result. A review of the published scientific data on the effects of mistletoe is also presented.
Keywords:
(18)F-FDG; Evaluación de respuesta; Evaluation of response; Homeopathy; Homeopatía; Linfoma; Lymphoma; PET/CT; PET/TC.
Copyright © 2016 Elsevier España, S.L.U. y SEMNIM. All rights reserved.
MeSH terms
-
Adult
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Agents, Phytogenic / adverse effects*
-
Antineoplastic Agents, Phytogenic / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bleomycin / administration & dosage
-
Dacarbazine / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Fluorine Radioisotopes / analysis*
-
Fluorodeoxyglucose F18 / analysis*
-
Hodgkin Disease / diagnostic imaging*
-
Hodgkin Disease / drug therapy
-
Humans
-
Injections, Subcutaneous
-
Lymph Nodes / diagnostic imaging*
-
Lymph Nodes / drug effects
-
Materia Medica / adverse effects*
-
Neoplasm Staging
-
Phytotherapy / adverse effects*
-
Positron Emission Tomography Computed Tomography*
-
Radiopharmaceuticals / analysis*
-
Ribosome Inactivating Proteins, Type 2 / administration & dosage
-
Ribosome Inactivating Proteins, Type 2 / adverse effects*
-
Ribosome Inactivating Proteins, Type 2 / therapeutic use
-
Self Medication
-
Subcutaneous Fat / diagnostic imaging
-
Subcutaneous Fat / metabolism
-
Toxins, Biological / administration & dosage
-
Toxins, Biological / adverse effects*
-
Toxins, Biological / therapeutic use
-
Vinblastine / administration & dosage
-
Viscum album / adverse effects*
Substances
-
Antineoplastic Agents, Phytogenic
-
Fluorine Radioisotopes
-
Materia Medica
-
Radiopharmaceuticals
-
Ribosome Inactivating Proteins, Type 2
-
Toxins, Biological
-
mistletoe lectin I
-
Fluorodeoxyglucose F18
-
Bleomycin
-
Vinblastine
-
Dacarbazine
-
Doxorubicin
-
Fluorine-18